Literature DB >> 20023205

Bile alcohols function as the ligands of membrane-type bile acid-activated G protein-coupled receptor.

Yusuke Iguchi1, Masafumi Yamaguchi, Hiroyuki Sato, Kenji Kihira, Tomoko Nishimaki-Mogami, Mizuho Une.   

Abstract

TGR5 is a G protein-coupled receptor that is activated by bile acids, resulting in an increase in cAMP levels and the subsequent modulation of energy expenditure in brown adipose tissue and muscle. Therefore, the development of a TGR5-specific agonist could lead to the prevention and treatment of various metabolic disorders related to obesity. In the present study, we evaluated the ability of bile alcohols, which are structurally and physiologically similar to bile acids and are produced as the end products of cholesterol catabolism in evolutionarily primitive vertebrates, to act as TGR5 agonists. In a cell-based reporter assay and a cAMP production assay performed in vitro, most bile alcohols with a side chain containing hydroxyl group(s) were highly efficacious agonists for TGR5 comparable to its most potent ligand in the naturally occurring bile acid, lithocholic acid. However, the abilities of the bile alcohols to activate TGR5 varied with the position and number of the hydroxyl substituent in the side chain. Additionally, the conformation of the steroidal nucleus of bile alcohols is also important for its activity as a TGR5 agonist. Thus, we have provided new insights into the structure-activity relationships of bile alcohols as TGR5 agonists.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20023205      PMCID: PMC3035506          DOI: 10.1194/jlr.M004051

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  42 in total

1.  Circadian distribution of bile acid in the enterohepatic circulatory system in hamsters.

Authors:  K J Ho
Journal:  J Lipid Res       Date:  1976-11       Impact factor: 5.922

2.  Study of reticuloendothelial phagocytic capacity in patients with cholestasis.

Authors:  G Drivas; O James; N Wardle
Journal:  Br Med J       Date:  1976-06-26

3.  Synthesis of (22R and 22S)-3 alpha, 7 alpha, 22-trihydroxy-5 beta-cholan-24-oic acids and structure of haemulcholic acid, a unique bile acid isolated from fish bile.

Authors:  K Kihira; Y Morioka; T Hoshita
Journal:  J Lipid Res       Date:  1981-11       Impact factor: 5.922

4.  Bile salts of frogs: a new higher bile acid, 3 alpha, 7 alpha, 12 alpha, 26-tetrahydroxy-5 beta-cholestanoic acid from the bile Rana plancyi.

Authors:  M Une; N Matsumoto; K Kihira; M Yasuhara; T Kuramoto; T Hoshita
Journal:  J Lipid Res       Date:  1980-03       Impact factor: 5.922

5.  Nongenomic actions of bile acids. Synthesis and preliminary characterization of 23- and 6,23-alkyl-substituted bile acid derivatives as selective modulators for the G-protein coupled receptor TGR5.

Authors:  Roberto Pellicciari; Hiroyuki Sato; Antimo Gioiello; Gabriele Costantino; Antonio Macchiarulo; Bahman M Sadeghpour; Gianluca Giorgi; Kristina Schoonjans; Johan Auwerx
Journal:  J Med Chem       Date:  2007-08-09       Impact factor: 7.446

6.  Synthesis of biological precursors of cholic acid.

Authors:  B Dayal; A K Batta; S Shefer; G S Tint; G Salen
Journal:  Steroids       Date:  1978-10       Impact factor: 2.668

7.  Structure-activity relationship of bile alcohols as human farnesoid X receptor agonist.

Authors:  Yusuke Iguchi; Kenji Kihira; Tomoko Nishimaki-Mogami; Mizuho Une
Journal:  Steroids       Date:  2009-11-12       Impact factor: 2.668

8.  The identification of urinary bile alcohols by gas chromatography-mass spectrometry in patients with liver disease and in healthy individuals.

Authors:  H Ludwig-Köhn; H V Henning; A Sziedat; D Matthaei; G Spiteller; J Reiner; H J Egger
Journal:  Eur J Clin Invest       Date:  1983-02       Impact factor: 4.686

9.  Synthesis of biological precursors of cholic acid II.

Authors:  B Dayal; G S Tint; A K Batta; S Shefer; G Salen
Journal:  Steroids       Date:  1981-02       Impact factor: 2.668

10.  Preparation of 24(R)- and 24(S)-5beta-cholestane-3alpha,7alpha,24-triols and 25(R)- and 25(S)-5beta-cholestane-3alpha,7alpha,26-triols by a hydroboration procedure.

Authors:  B Dayal; A K Batta; S Shefer; G S Tint; G Salen; E H Mosbach
Journal:  J Lipid Res       Date:  1978-02       Impact factor: 5.922

View more
  9 in total

1.  Hydrophobic bile salts inhibit gallbladder smooth muscle function via stimulation of GPBAR1 receptors and activation of KATP channels.

Authors:  Brigitte Lavoie; Onesmo B Balemba; Cody Godfrey; Conall A Watson; Galya Vassileva; Carlos U Corvera; Mark T Nelson; Gary M Mawe
Journal:  J Physiol       Date:  2010-07-12       Impact factor: 5.182

Review 2.  FXR signaling in the enterohepatic system.

Authors:  Tsutomu Matsubara; Fei Li; Frank J Gonzalez
Journal:  Mol Cell Endocrinol       Date:  2012-05-17       Impact factor: 4.102

Review 3.  The human gut microbiota: Metabolism and perspective in obesity.

Authors:  Aline Corado Gomes; Christian Hoffmann; João Felipe Mota
Journal:  Gut Microbes       Date:  2018-05-24

Review 4.  Pleiotropic functions of the organic solute transporter Ostα-Ostβ.

Authors:  Nazzareno Ballatori
Journal:  Dig Dis       Date:  2011-06-17       Impact factor: 2.404

5.  Nonacidic Chemotype Possessing N-Acylated Piperidine Moiety as Potent Farnesoid X Receptor (FXR) Antagonists.

Authors:  Naoki Teno; Yukiko Yamashita; Yusuke Iguchi; Ko Fujimori; Mizuho Une; Tomoko Nishimaki-Mogami; Takie Hiramoto; Keigo Gohda
Journal:  ACS Med Chem Lett       Date:  2018-01-04       Impact factor: 4.345

6.  Cholesterol metabolite, 5-cholesten-3β-25-diol-3-sulfate, promotes hepatic proliferation in mice.

Authors:  Xin Zhang; Qianming Bai; Genta Kakiyama; Leyuan Xu; Jin Kyung Kim; William M Pandak; Shunlin Ren
Journal:  J Steroid Biochem Mol Biol       Date:  2012-06-23       Impact factor: 4.292

7.  Discovery of Orally Active and Nonsteroidal Farnesoid X Receptor (FXR) Antagonist with Propensity for Accumulation and Responsiveness in Ileum.

Authors:  Naoki Teno; Yusuke Iguchi; Keisuke Oda; Yukiko Yamashita; Arisa Masuda; Ko Fujimori; Mizuho Une; Keigo Gohda
Journal:  ACS Med Chem Lett       Date:  2021-02-24       Impact factor: 4.345

8.  Synthesis of Novel Farnesoid X Receptor Agonists and Validation of Their Efficacy in Activating Differentiation of Mouse Bone Marrow-Derived Mesenchymal Stem Cells into Osteoblasts.

Authors:  Ko Fujimori; Yusuke Iguchi; Yukiko Yamashita; Keigo Gohda; Naoki Teno
Journal:  Molecules       Date:  2019-11-16       Impact factor: 4.411

9.  Using nontargeted LC-MS metabolomics to identify the Association of Biomarkers in pig feces with feed efficiency.

Authors:  Jie Wu; Yong Ye; Jianping Quan; Rongrong Ding; Xingwang Wang; Zhanwei Zhuang; Shenping Zhou; Qian Geng; Cineng Xu; Linjun Hong; Zheng Xu; Enqin Zheng; Gengyuan Cai; Zhenfang Wu; Jie Yang
Journal:  Porcine Health Manag       Date:  2021-06-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.